Answers are grounded in this paper and cite their sources.
Mendelian randomization analysis reveals that gut microbiota significantly affects 28-day mortality in sepsis, suggesting new therapeutic avenues.
Sepsis, which is characterized by the failure of multiple organ, is the leading cause of death in intensive care units. Extensive research has emphasized a significant link between sepsis and the gut microbiota (GM). However, the causal relationship between these two factors, specifically the impact on 28-day mortality, remains unclear. We conducted a Mendelian randomization (MR) study utilizing genome-wide association study (GWAS) summary statistics. The primary analysis method used to establish the causal relationship was the inverse-variance weighted (IVW) method, along with four other MR methods. Furthermore, we assessed heterogeneity and horizontal pleiotropy using Cochran's Q test, MR-Egger intercept test, respectively. The IVW method showed that 7 GM, mainly including class Bacteroidia [odd ratio (OR) 1.565, 95% confidence interval (CI) 1.161-2.108, P = 0.003], genus Methanobrevibacter (OR 1.347, 95% CI 1.045-1.736, P = 0.022) and others were positively associated with 28-day sepsis mortality. Conversely, genetically predicted 4 GM, including class Lentisphaeria (OR 0.751, 95% CI 0.588-0.960, P = 0.022), genus Coprococcus2 (OR 0.537, 95% CI 0.315-0.917, P = 0.023), and others were negatively related to 28-day sepsis mortality. Heterogeneity and pleiotropy analyses also confirmed the robustness of our findings (all P > 0.05). Our study demonstrated a causal relationship between GM and 28-day mortality in sepsis using MR methods from a genetic perspective, wihich provides prospects for future microbiome-based therapeutics target in sepsis.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: